Search

Your search keyword '"Di Napoli, M."' showing total 528 results

Search Constraints

Start Over You searched for: Author "Di Napoli, M." Remove constraint Author: "Di Napoli, M."
528 results on '"Di Napoli, M."'

Search Results

1. Management of Metastatic Disease in Campania (MAMETIC): An Observational Multicenter Retrospective and Prospective Trial on Palliative Radiotherapy in an Italian Region. Study Protocol

4. PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives

5. Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial

8. Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer

9. Inadequate PROs and HRQoL reporting in phase III advanced genitourinary tumors RCTs

11. Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma compared to patients with advanced solid tumours

14. Signs and symptoms of COVID-19 in patients with multiple sclerosis

16. 52P Real-world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group

19. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

20. Signs and symptoms of COVID-19 in patients with multiple sclerosis

21. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

23. Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel

24. Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies

26. The Italian multiple sclerosis register

28. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

31. Regular physical activity postpones age of occurrence of first-ever stroke and improves long-term outcomes.

32. Slow-moving landslide risk assessment combining Machine Learning and InSAR techniques

33. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

35. LBA82 Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study

36. COVID-19 pandemic and burden of non-communicable diseases: An ecological study on data of 185 countries.

37. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE)

38. Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results

39. Correlations between COVID-19 and burden of dementia: An ecological study and review of literature

40. COVID-19 Pandemic and Burden of Non-Communicable Diseases: An Ecological Study on Data of 185 Countries

41. Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

42. Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel

43. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

44. Geomorphology of Cinque Terre National Park (Italy).

46. pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics

47. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data

48. Diagnostic accuracy of Hybrid Capture 2 test: Results obtained from internal quality control

49. Long-term tolerability of olaparib tablets as maintenance therapy for platinum-sensitive relapsed ovarian cancer (PSR OC): Phase III SOLO2 trial

Catalog

Books, media, physical & digital resources